SV1999000152A - Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial - Google Patents
Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacialInfo
- Publication number
- SV1999000152A SV1999000152A SV1999000152A SV1999000152A SV1999000152A SV 1999000152 A SV1999000152 A SV 1999000152A SV 1999000152 A SV1999000152 A SV 1999000152A SV 1999000152 A SV1999000152 A SV 1999000152A SV 1999000152 A SV1999000152 A SV 1999000152A
- Authority
- SV
- El Salvador
- Prior art keywords
- guai
- space control
- drugs
- drug
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA EN FORMA DE TABLETAS O CAPSULAS PROVEE UNA COMBINACION DE CONTROL TEMPORAL Y ESPACIAL DE LIBERACION DE UNA DROGA A UN PACIENTE PARA RESULTADOS TERAPEUTICOS EFECTIVOS. LA COMPOSICION FARMACEUTICA COMPRENDE UNA DROGA, UN COMPONENTE GENERADOR DE GAS, UN AGENTE DILATADOR, UN AGENTE VISCOSO, Y OPCIONALMENTE UN POLIMERO FORMADOR DE GEL. EL AGENTE DILATADOR PERTENECE A UN GRUPO DE COMPUESTOS CONOCIDOS COMO SUPERDESINTEGRADORES (POR EJEMPLO: LA POLIVINILPIRROLIDONA DE ENLACE CRUZADO O LA CARBOXIMETILCELULOSA DE SODIO) INICIALMENTE EL AGENTE VISCOSO Y LUEGO EL POLIMERO FORMADOR DE GEL, FORMAN UNA MATRIZ DE GEL HIDRATADA QUE OCLUYE EL GAS, CAUSANDO QUE LA TABLETA O CAPSULA FLOTEN PARA SER RETENIDAS EN EL ESTOMAGO O EN LA PARTE ALTA DEL INTESTINO DELGADO (CONTROL ESPACIAL). AL MISMO TIEMPO LA MATRIZ DEL GEL HIDRATADO CREA UN CAMINO DE DIFUSION TORTUOSO PARA LA DROGA, LO QUE RESULTA EN UNA LIBERACION SOSTENIDA DE LA DROGA(CONTROL TEMPORAL). UNA FORMULACION, PREFERIDA, DE CIPROFLOXACIN ADMINISTRADA UNA SOLA VEZ AL DIA COMPRENDE 69.9% DE BASE DE CIPROFLOXACIN , 0.34% DE ALGINATO DE SODIO, 1.03% DE GOMA JANTICA, 13.7% DE BICARBONATO DE SODIO, 12.1% DE POLIVINILPIRROLIDONA DE ENLAZE CRUZADO, Y OPCIONALMENTE OTROS EXCIPIENTES FARMACEUTICOS, LA FORMULACION ESTA EN FORMA DE TABLETAS RECUBIERTAS O NO, O EN CAPSULAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/152,932 US6261601B1 (en) | 1997-09-19 | 1998-09-14 | Orally administered controlled drug delivery system providing temporal and spatial control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV1999000152A true SV1999000152A (es) | 2000-07-03 |
Family
ID=22545063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV1999000152A SV1999000152A (es) | 1998-09-14 | 1999-09-13 | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial |
Country Status (41)
| Country | Link |
|---|---|
| EP (2) | EP1281397A1 (es) |
| JP (1) | JP2002524494A (es) |
| CN (1) | CN1186013C (es) |
| AP (1) | AP1659A (es) |
| AR (1) | AR022672A1 (es) |
| AT (1) | ATE245414T1 (es) |
| AU (1) | AU758324B2 (es) |
| BG (1) | BG105339A (es) |
| BR (1) | BR9913696A (es) |
| CA (1) | CA2343760A1 (es) |
| CO (1) | CO5130022A1 (es) |
| CU (1) | CU23040A3 (es) |
| CZ (1) | CZ2001901A3 (es) |
| DE (1) | DE69909801T2 (es) |
| DK (1) | DK1107741T3 (es) |
| EA (2) | EA004443B1 (es) |
| EE (1) | EE200100153A (es) |
| ES (1) | ES2204098T3 (es) |
| GE (1) | GEP20043216B (es) |
| HK (1) | HK1037967A1 (es) |
| HR (1) | HRP20010187B1 (es) |
| HU (1) | HUP0103632A3 (es) |
| ID (1) | ID29843A (es) |
| IL (1) | IL141977A0 (es) |
| IS (1) | IS5885A (es) |
| MX (1) | MXPA01002634A (es) |
| MY (1) | MY127952A (es) |
| NO (1) | NO20011276L (es) |
| NZ (2) | NZ510487A (es) |
| OA (1) | OA11652A (es) |
| PE (1) | PE20001058A1 (es) |
| PL (1) | PL346798A1 (es) |
| PT (1) | PT1107741E (es) |
| SI (1) | SI1107741T1 (es) |
| SK (1) | SK285478B6 (es) |
| SV (1) | SV1999000152A (es) |
| TR (1) | TR200100731T2 (es) |
| UA (1) | UA73287C2 (es) |
| UY (1) | UY25710A1 (es) |
| WO (1) | WO2000015198A1 (es) |
| ZA (1) | ZA995839B (es) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030009374A (ko) * | 2000-03-03 | 2003-01-29 | 랜박시 래보러터리스 리미티드 | 시프로플록사신의 1일 1회 투여를 위한 경구 투여용제어된 전달 시스템 |
| AU2006202275A1 (en) * | 2000-06-26 | 2006-06-22 | Bayer Healthcare Ag | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| US6861071B2 (en) * | 2000-08-08 | 2005-03-01 | Daiichi Pharmaceutical Co., Ltd. | Highly absorptive solid preparation |
| IN192748B (es) * | 2000-08-29 | 2004-05-15 | Ranbaxy Lab Ltd | |
| CA2431205C (en) | 2000-12-05 | 2005-08-23 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
| MXPA03012041A (es) | 2001-07-04 | 2004-03-26 | Sun Pharmaceutical Ind Ltd | Sistema de administracion controlada de farmacos de retencion gastrica. |
| PL368327A1 (en) * | 2001-08-16 | 2005-03-21 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Expandable gastric retention device |
| US6673369B2 (en) * | 2001-08-29 | 2004-01-06 | Ranbaxy Laboratories Limited | Controlled release formulation |
| AU2002351798A1 (en) * | 2001-10-29 | 2003-05-12 | Labopharm Inc. | Methods and dosage forms for improving the bioavailability of therapeutic agents |
| RU2322263C2 (ru) * | 2001-11-13 | 2008-04-20 | Астеллас Фарма, Инк. | Система продолжительного высвобождения растворимого лекарственного средства |
| PT1461017E (pt) | 2001-11-19 | 2006-07-31 | Lupin Ltd | Composicao farmaceutica para a libertacao controlada de um antibiotico beta-lactamico |
| DE60219965T2 (de) * | 2002-04-23 | 2008-01-17 | Lupin Ltd., Mumbai | Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine |
| WO2005018613A1 (de) * | 2003-08-26 | 2005-03-03 | Mandapro Ag | Pellets für die orale applikation von pharmazeutischen wirkstoffen |
| DE102004042139B4 (de) * | 2004-08-31 | 2009-06-10 | Aristocon Verwaltungs- Gmbh | Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit |
| GB0501810D0 (en) * | 2005-01-28 | 2005-03-09 | Pharmakodex Ltd | Chemotherapeutic formulations |
| US20090099154A1 (en) * | 2005-06-29 | 2009-04-16 | Panacea Biotec Ltd. | Pharmaceutical Sustained Release Compositions and Processes Thereof |
| ATE396710T1 (de) * | 2005-07-19 | 2008-06-15 | Ethypharm Sa | Gastroretentive zusammensetzungen und verfahren zur herstellung |
| GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
| KR20080076382A (ko) * | 2007-02-15 | 2008-08-20 | (주)아모레퍼시픽 | 실로스타졸의 제어방출 제제 및 그 제조방법 |
| WO2010020098A1 (zh) | 2008-08-18 | 2010-02-25 | 北京天衡药物研究院 | 胃滞留药物释出系统及其制备方法和用途 |
| ZA200903854B (en) * | 2008-06-19 | 2011-02-23 | Univ Of The Witwatesrand Johannesburg | A gastroretentive pharmaceutical dosage form |
| WO2011125075A2 (en) | 2010-04-08 | 2011-10-13 | Fdc Limited | A novel gastroretentive delivery of macrolide |
| EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
| TWI705814B (zh) * | 2014-06-20 | 2020-10-01 | 美商梅琳塔有限責任公司 | 醫藥組成物及其用途 |
| US11504324B2 (en) | 2014-11-19 | 2022-11-22 | DuPont Nutrition USA, Inc. | Nanosuspension formulation |
| US10987311B2 (en) | 2017-06-16 | 2021-04-27 | Kashiv Specialty Pharmaceuticals, Llc | Extended release compositions comprising pyridostigmine |
| CN110996922A (zh) | 2017-06-16 | 2020-04-10 | 卡希夫生物科学有限责任公司 | 用于持续药物递送的胃滞留剂型 |
| US10588863B2 (en) | 2017-06-16 | 2020-03-17 | Kashiv Biosciences, Llc | Extended release compositions comprising pyridostigmine |
| EP4056172A1 (en) | 2018-06-18 | 2022-09-14 | Amneal Complex Products Research LLC | Extended release compositions comprising pyridostigmine |
| WO2020006278A1 (en) | 2018-06-27 | 2020-01-02 | Kashiv Biosciences, Llc | Self-regulating osmotic gastroretentive drug delivery systems |
| CN110448535A (zh) * | 2019-09-04 | 2019-11-15 | 湖南宇山玉月农业科技有限公司 | 一种裂褶菌素胃漂浮片 |
| CN111116794A (zh) * | 2019-12-20 | 2020-05-08 | 蚌埠市鑫晟新材料科技有限公司 | 一种中性造纸用聚合材料的制备方法 |
| CN115715765A (zh) * | 2021-08-24 | 2023-02-28 | 江苏万邦生化医药集团有限责任公司 | 一种悬浮片剂 |
| CN113768898A (zh) * | 2021-09-14 | 2021-12-10 | 江苏万邦生化医药集团有限责任公司 | 悬浮的胶囊片 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0798742B2 (ja) * | 1986-07-03 | 1995-10-25 | ゼリア新薬工業株式会社 | 徐放性製剤組成物 |
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
-
1999
- 1999-01-19 ES ES99900106T patent/ES2204098T3/es not_active Expired - Lifetime
- 1999-01-19 AU AU17794/99A patent/AU758324B2/en not_active Ceased
- 1999-01-19 BR BR9913696-1A patent/BR9913696A/pt not_active IP Right Cessation
- 1999-01-19 GE GEAP19995796A patent/GEP20043216B/en unknown
- 1999-01-19 HU HU0103632A patent/HUP0103632A3/hu unknown
- 1999-01-19 EP EP02023169A patent/EP1281397A1/en not_active Withdrawn
- 1999-01-19 NZ NZ510487A patent/NZ510487A/xx unknown
- 1999-01-19 TR TR2001/00731T patent/TR200100731T2/xx unknown
- 1999-01-19 SK SK347-2001A patent/SK285478B6/sk unknown
- 1999-01-19 IL IL14197799A patent/IL141977A0/xx unknown
- 1999-01-19 CZ CZ2001901A patent/CZ2001901A3/cs unknown
- 1999-01-19 CA CA002343760A patent/CA2343760A1/en not_active Abandoned
- 1999-01-19 NZ NZ523747A patent/NZ523747A/en unknown
- 1999-01-19 EA EA200100346A patent/EA004443B1/ru not_active IP Right Cessation
- 1999-01-19 OA OA1200100064A patent/OA11652A/en unknown
- 1999-01-19 MX MXPA01002634A patent/MXPA01002634A/es not_active Application Discontinuation
- 1999-01-19 SI SI9930376T patent/SI1107741T1/xx unknown
- 1999-01-19 EP EP99900106A patent/EP1107741B1/en not_active Expired - Lifetime
- 1999-01-19 EE EEP200100153A patent/EE200100153A/xx unknown
- 1999-01-19 EA EA200300847A patent/EA005767B1/ru not_active IP Right Cessation
- 1999-01-19 AP APAP/P/2001/002098A patent/AP1659A/en active
- 1999-01-19 ID IDW20010594A patent/ID29843A/id unknown
- 1999-01-19 WO PCT/IB1999/000078 patent/WO2000015198A1/en not_active Application Discontinuation
- 1999-01-19 CU CU20010067A patent/CU23040A3/es unknown
- 1999-01-19 AT AT99900106T patent/ATE245414T1/de not_active IP Right Cessation
- 1999-01-19 UA UA2001031727A patent/UA73287C2/uk unknown
- 1999-01-19 DE DE69909801T patent/DE69909801T2/de not_active Expired - Fee Related
- 1999-01-19 CN CNB998129887A patent/CN1186013C/zh not_active Expired - Fee Related
- 1999-01-19 PT PT99900106T patent/PT1107741E/pt unknown
- 1999-01-19 JP JP2000569782A patent/JP2002524494A/ja active Pending
- 1999-01-19 PL PL99346798A patent/PL346798A1/xx unknown
- 1999-01-19 DK DK99900106T patent/DK1107741T3/da active
- 1999-09-10 ZA ZA9905839A patent/ZA995839B/xx unknown
- 1999-09-13 MY MYPI99003949A patent/MY127952A/en unknown
- 1999-09-13 SV SV1999000152A patent/SV1999000152A/es not_active Application Discontinuation
- 1999-09-13 PE PE1999000924A patent/PE20001058A1/es not_active Application Discontinuation
- 1999-09-14 CO CO99058020A patent/CO5130022A1/es unknown
- 1999-09-14 UY UY25710A patent/UY25710A1/es unknown
- 1999-09-17 AR ARP990104682A patent/AR022672A1/es not_active Application Discontinuation
-
2001
- 2001-03-12 IS IS5885A patent/IS5885A/is unknown
- 2001-03-13 HR HR20010187A patent/HRP20010187B1/xx not_active IP Right Cessation
- 2001-03-13 NO NO20011276A patent/NO20011276L/no unknown
- 2001-03-13 BG BG105339A patent/BG105339A/xx unknown
- 2001-12-11 HK HK01108695A patent/HK1037967A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV1999000152A (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
| YU19501A (sh) | Sistem za kontrolisano davanje lekova oralnim putem koji obezbeđuje vremensku i prostornu kontrolu | |
| ES2200166T3 (es) | Comprimido farmaceutico de liberacion controlada que contiene un soporte a base de amilosa reticulada e hidroxipropilmetilcelulosa. | |
| Sinha et al. | Bioabsorbable polymers for implantable therapeutic systems | |
| IL143375A0 (en) | Sustained release matrix systems for highly soluble drugs | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| KR20010102088A (ko) | 질에 투여되는 연장방출 생물접착성 겔약형 | |
| AR039744A1 (es) | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada | |
| BR0112532A (pt) | Composição farmacêutica oral, sistema galênico e uso da composição | |
| AR004391A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles. | |
| AU7465087A (en) | Controlled release bioerodible drug delivery system | |
| KR910007518A (ko) | 서방성 제제 | |
| KR880010758A (ko) | 서방성 제제 | |
| AR062167A1 (es) | Sistema de administracion gastrorretentivo | |
| Tiwari et al. | Oral drug delivery system: a review | |
| ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
| HN2001000038A (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
| US20110301213A1 (en) | Use of pilocarpine for hypoptyalism treatment | |
| US20070148227A1 (en) | Physically/molecularly distributed and/or chemically bound medicaments in capsule shells | |
| ECSP993138A (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
| US6663896B1 (en) | Delayed release aspirin for vascular obstruction prophylaxis | |
| Das et al. | A Systematic Review on Drug Delivery Systems Based on Their Mechanism of Drug Release and Their Applications | |
| TH50543A3 (th) | ระบบการนำส่งยาที่ควบคุมได้สำหรับให้ทางปากซึ่งให้การควบคุมเกี่ยวกับเวลาและบริเวณ | |
| Mahajan et al. | An overview on Superdisintegrants | |
| Kiran | Preparation and Evaluation of Inter Polymer Complex Microspheres Containing a Steroidal Drug for Arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant | ||
| FD | Lapse |